Skip to main content
Bulletin of the National Research Centre

Table 3 Newly designed 2-anilinopyrimidine compounds against MBA-MB-468 cell line

From: Computational pharmacokinetic analysis on some newly designed 2-anilinopyrimidine derivative compounds as anti-triple-negative breast cancer drug compounds

Back to article page